-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
From November 12th to 14th, the world's first COVID-19 inhalable vaccine was unveiled at the "2021 China Fifth Hainan International Health Industry Expo"
It is understood that the new coronavirus inhalation vaccine and intramuscular injection use the same vaccine.
Nebulized inhalation immunity is the use of a nebulizer to atomize vaccine into tiny particles, which are inhaled into the respiratory tract and lungs through the mouth, thereby stimulating mucosal immunity that cannot be brought about by intramuscular injection
The team of Academician Chen Wei of the Academy of Military Medical Sciences and Cansino Biological Co.
No vaccination
Previously, the new coronary pneumonia aerosol inhalation vaccine developed by Academician Chen Wei's team published clinical research data in the journal "Lancet Infectious Diseases".
The research results show that the safety of nebulized inhalation vaccination is good, and there is no local adverse reaction of intramuscular injection
After intramuscular injection, nebulized inhalation can enhance immunity and produce high levels of neutralizing antibodies
Compared with the intramuscular vaccines currently approved for marketing, the formula, packaging and production facilities of the vaccine are exactly the same
(Source: Internet, reference only)
